The Diversity Webinar Series features panels of industry experts sharing knowledge, best practices, and regulatory guidance to increase representation and engagement of diverse populations in clinical trials.
Financial Implications of Diversity Strategy
David Vulcano, SCRS
Van Johnson, Velocity Clinical Research
Nicholas Kenny, Syneos Health
Fabian Sandoval, MD, Emerson Clinical Research Institute
Diversity Plan Impacts
Bella Johnson, Kalo Research
April Coburn, ICON
Katy Armstrong, Genentech
Seneca Harrison, Quality Clinical Research
Racial Diversity in Clinical Trials and Why It’s Important to Help Us Advance
Diversity, Equity and Inclusion: Digging Deeper into Clinical Trial Participation Barriers on a Global Level
Diana Foster, Vice President, Strategy and Special Projects, SCRS
Brandon Doyle, Associate Director, SIte Alliances, Parexel
Fabian Sandoval, MD, CEO & Medical Director, Emerson Clinical Research Institute
Dace Dimza-Jones, Business Development Manager/Industry Facilitator, NIHR Clinical Research Network Greater Manchester
Bindhu Xavier, Senior Clinical Research Nurse, NIHR Clinical Research Network Greater Manchester
Nikesh Patel, Business Development Executive, MIDAS
Diversity Recruitment and Retention: How Identifying Gaps Leads to Building Patient Trust
Clare Grace, PhD, Chief Patient Officer, Parexel
Maimah Karmo, Founder & President, TigerLily Fdtn.
Jackie Kent, Chief Customer Officer, Medidata Solutions
Kimberly Richardson, Founder & President, Black Cancer Collaborative
Fabian Sandoval, MD, CEO & Research Director, Emerson Clinical Research Institute
Under Construction! Practical Considerations and Tactics for Increasing Inclusiveness in Research
Ayoade Avworo, DNP, APRN, FNP-BC, Investigator, Clinical Trials of Texas
Theo Christie, Business Development Manager, NIHR
Van Johnson, Vice President – Commercial Strategy/Director, M.A.C.R.O., Benchmark Research
Irfan Khan, M.D., CEO, Circuit Clinical
Earl Seltzer, Sr. Director Feasibility, Covance
FDA Efforts to Advance the Inclusion of Women and Minorities in Clinical Trials
Richardae Araojo, PharmD, MS Associate Commissioner for Minority Health Director, Office of Minority Health & Health Equity U.S. FDA
Kaveeta P. Vasisht, MD, PharmD Associate Commissioner for Women’s Health Director, Office of Women’s Health Office of the Commissioner U.S. FDA
The Scientific and Ethical Imperative for Patient Diversity in Clinical Trials
Nicholas Kenny, Chief Scientific Officer, Syneos Health
Lorena Kuri, Diversity Strategy/Global Clinical Trial Planning & Alliances, Bristol Myers Squibb
How Can We Be More Inclusive to Minorities in Clinical Research – The Site & Patient Voice Matters!
Marta Nelson, Partner, MplusM Consulting
Tracey Osborn, Site Director, Innovative Research of West Florida
Karri Venn, President, LMC Manna Research